Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1643 studies found for:    "Hepatitis, Chronic"
Show Display Options
RSS Create an RSS feed from your search for:
"Hepatitis, Chronic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology Consortium
Condition: Hepatitis, Chronic
Intervention: Drug: Sofosbuvir, Ribavirin, With or Without Pegylated Interferon
2 Completed Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
Condition: Hepatitis, Chronic
Intervention:
3 Terminated Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine
Condition: Hepatitis, Chronic
Interventions: Drug: Lamivudine;   Drug: Telbivudine
4 Completed Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention:
5 Completed Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Nitazoxanide
6 Terminated Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Procedure: therapeutic drug monitoring of ribavirin and dose adaptation
7 Active, not recruiting The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg
Condition: Chronic Hepatitis B
Intervention: Drug: peginterferon alfa
8 Recruiting Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues
Condition: Chronic Hepatitis B
Interventions: Drug: Continue NA treatment;   Drug: Discontinue NA Treatment
9 Completed CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study
Condition: Chronic Hepatitis B
Intervention: Other: No intervention
10 Recruiting The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Metacavir Enteric-coated Capsules 80mg;   Drug: Metacavir Enteric-coated Capsules 160mg;   Drug: Metacavir Enteric-coated Capsules 320mg;   Drug: Metacavir Enteric-coated Capsules Placebo 240mg;   Drug: Metacavir Enteric-coated Capsules Placebo 160mg;   Drug: Metacavir Enteric-coated Capsules Placebo 320mg;   Drug: Adefovir Dipivoxil Capsule10mg;   Drug: Adefovir Dipivoxil Capsule Placebo 10mg
11 Completed
Has Results
Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Ursodeoxycholic acid 150mg / day;   Drug: Ursodeoxycholic acid 600mg / day;   Drug: Ursodeoxycholic acid 900mg / day
12 Recruiting Mechanisms Associated With Favorable Responses to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)Ide Analogue Treatment in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Peginterferon alfa-2a
13 Completed Effect of Camel Milk on Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon, Ribavirin, camel milk;   Drug: Peginterferon, Ribavirin
14 Completed Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)
Condition: Chronic Hepatitis C
Intervention: Procedure: Comparator: Fine needle aspiration biopsy
15 Unknown  Therapeutic Hepatitis B Vaccine (Synthesized Peptide) in Treating Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Biological: The therapeutic (synthesized peptide) HBV vaccine (εPA-44);   Biological: Placebo
16 Recruiting Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
Condition: Chronic Hepatitis b
Intervention: Drug: Entecavir or Tenofovir
17 Completed Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Pegylated Interferon-alpha2a;   Drug: Thymosin alpha1 & Pegylated Interferon-alpha2a
18 Completed Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients
Condition: Chronic Hepatitis C
Intervention: Biological: Albinterferon alfa 2b
19 Terminated Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Procedure: Blood sampling of peripheral blood mononuclear cells;   Procedure: Blood draw, 20ml peripheral blood mononuclear cells
20 Terminated Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.
Condition: Chronic Hepatitis B
Intervention: Drug: ACH-126, 443 (beta-L-Fd4C)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.